Journal Article

Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis

Zenesini, Corrado, Capellari, Sabina, Vacchiano, Veria, Polischi, Barbara, Salvi, Fabrizio, Liguori, Rocco, Fileccia, Enrico, de Pasqua, Silvia, Mammana, Angela, Abu-Rumeileh, Samir, Di Stasi, Vitantonio, Parchi, Piero

2020

Overview

Neurofilament light chain protein (NfL) is currently the most accurate cerebrospinal fluid (CSF) biomarker in amyotrophic lateral sclerosis (ALS) in terms of both diagnostic and prognostic value, but the mechanism underlying its increase is still a matter of debate. Similarly, emerging CSF biomarkers of neurodegeneration and neuroinflammation showed promising results, although further studies are needed to clarify their clinical and pathophysiological roles. In the present study we compared the diagnostic accuracy of CSF NfL, phosphorylated (p)-tau/total (t)-tau ratio, chitinase-3-like protein 1 (YKL-40) and chitotriosidase 1 (CHIT1), in healthy controls ( n  = 43) and subjects with ALS ( n  = 80) or ALS mimics ( n  = 46). In ALS cases, we also investigated the association between biomarker levels and clinical variables, the extent of upper motor neuron (UMN) and lower motor neuron (LMN) degeneration, and denervation activity through electromyography (EMG). ALS patients showed higher levels of CSF NfL, YKL-40, CHIT1, and lower values of p-tau/t-tau ratio compared to both controls and ALS mimics. Among all biomarkers, NfL yielded the highest diagnostic performance (> 90% sensitivity and specificity) and was the best predictor of disease progression rate and survival in ALS. NfL levels showed a significant  correlation with the extent of LMN involvement, whereas YKL-40 levels increased together with the number of areas showing both UMN and LMN damage. EMG denervation activity did not correlate with any CSF biomarker change. These findings confirm the highest value of NfL among currently available CSF biomarkers for the diagnostic and prognostic assessment of ALS and contribute to the understanding of the pathophysiological and electrophysiological correlates of biomarker changes.

• Publisher: Springer Berlin Heidelberg,Springer Nature B.V
• Subject: Aged / Amyotrophic lateral sclerosis / Amyotrophic Lateral Sclerosis - cerebrospinal fluid / Amyotrophic Lateral Sclerosis - diagnosis / Amyotrophic Lateral Sclerosis - physiopathology / Biomarkers / Biomarkers - cerebrospinal fluid / Cerebrospinal fluid / Chitinase / Chitinase-3-Like Protein 1 - cerebrospinal fluid / Denervation / Disease Progression / Electromyography / Female / Hexosaminidases - cerebrospinal fluid / Humans / Inflammation / Male / Medicine / Medicine & Public Health / Middle Aged / Neurodegeneration / Neurofilament Proteins - cerebrospinal fluid / Neurology / Neuroradiology / Neurosciences / Original Communication / Prognosis / Sensitivity and Specificity / Tau protein / tau Proteins - cerebrospinal fluid